To investigate the protective and therapeutic effect of the DNA vaccine pcDNA3.1-VNTR against pancreatic cancer, we first constructed a murine pancreatic cancer cell which could express the human MUC1 protein and mainly on the cell membrane (Figure 1 and Figure 2). The gene discussed is MUC1; the disease is familial pancreatic carcinoma.